申请人:E. R. Squibb & Sons, Inc.
公开号:US04214081A1
公开(公告)日:1980-07-22
Compounds having the formula ##STR1## or a pharmaceutically acceptable salt thereof, wherein R.sub.1 is alkyl, cycloalkyl or aryl; R.sub.2 is acyl or sulfonyl; R.sub.3 is alkylamino, dialkylamino or a nitrogen containing heterocyclic group; R.sub.4 is alkoxy; A.sub.1 is a saturated bond or an alkylene group having 1 to 4 carbon atoms; and A.sub.2 is an alkylene group having 2 to 5 carbon atoms; have antiinflammatory activity.
具有以下结构式##STR1##或其药学上可接受的盐,其中R.sub.1是烷基、环烷基或芳基;R.sub.2是酰基或磺酰基;R.sub.3是烷基氨基、二烷基氨基或含氮杂环基团;R.sub.4是烷氧基;A.sub.1是饱和键或具有1至4个碳原子的烷基链;A.sub.2是具有2至5个碳原子的烷基链;具有抗炎活性。